Spitzer M, Robbins N, Wright GD. Combinatorial strategies for combating invasive fungal infections. Virulence. 2017;8:169–85. https://doi.org/10.1080/21505594.2016.1196300.

Article  CAS  PubMed  Google Scholar 

Mohr J, Johnson M, Cooper T, et al. Current options in antifungal pharmacotherapy. Pharmacotherapy. 2008;28:614–45. https://doi.org/10.1592/PHCO.28.5.614.

Article  CAS  PubMed  Google Scholar 

Georgopapadakou NH, Walsh TJ. Antifungal agents: chemotherapeutic targets and immunologic strategies. Antimicrob Agents Chemother. 1996;40:279–91. https://doi.org/10.1128/AAC.40.2.279.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Robbins N, Wright GD, Cowen LE. Antifungal drugs: the current armamentarium and development of new agents. Microbiol Spectr. 2016;4.  https://doi.org/10.1128/MICROBIOLSPEC.FUNK-0002-2016

Negri M, Salci TP, Shinobu-Mesquita CS, et al. Early state research on antifungal natural products. Molecules. 2014;19:2925. https://doi.org/10.3390/MOLECULES19032925.

Article  PubMed  PubMed Central  Google Scholar 

Johnson MD, Perfect JR. Combination antifungal therapy: what can and should we expect? Bone Marrow Transpl. 2007;40:297–306. https://doi.org/10.1038/sj.bmt.1705687.

Article  CAS  Google Scholar 

Niazi-Ali S, Atherton GT, Walczak M, Denning DW. Drug-drug interaction database for safe prescribing of systemic antifungal agents. Ther Adv Infect Dis. 2021;8. https://doi.org/10.1177/20499361211010605

Rossato L, Camargo dos Santos M, Vitale RG, et al. Alternative treatment of fungal infections: synergy with non-antifungal agents. Mycoses. 2021;64:232–44. https://doi.org/10.1111/MYC.13203.

Article  PubMed  Google Scholar 

Graybill JR. Antifungal drugs and resistance. Adv Exp Med Biol. 1996;390:217–34. https://doi.org/10.1007/978-1-4757-9203-4_19.

Article  Google Scholar 

Campitelli M, Zeineddine N, Samaha G, Maslak S. Combination antifungal therapy: a review of current data. J Clin Med Res. 2017;9:451–6. https://doi.org/10.14740/JOCMR2992W.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lepak AJ, Andes DR. Antifungal pharmacokinetics and pharmacodynamics. Cold Spring Harb Perspect Med. 2015. https://doi.org/10.1101/cshperspect.a019653.

Article  PubMed Central  Google Scholar 

Hamill RJ. Amphotericin B formulations: a comparative review of efficacy and toxicity. Drugs. 2013;73:919–34. https://doi.org/10.1007/S40265-013-0069-4.

Article  CAS  PubMed  Google Scholar 

Sugar AM. Use of Amphotericin B with azole antifungal drugs: what are we doing? Antimicrob Agents Chemother. 1995;39:1907–12. https://doi.org/10.1128/AAC.39.9.1907.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ghannoum M, Isham N. Terbinafine. Kucers the use of antibiotics: a clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs, 7th edn 2709–2719. https://doi.org/10.1201/9781315152110

Gupta AK, Katz HI, Shear NH. Drug interactions with Itraconazole, Fluconazole, and Terbinafine and their management. J Am Acad Dermatol. 1999;41:237–49. https://doi.org/10.1016/S0190-9622(99)70055-1.

Article  CAS  PubMed  Google Scholar 

Deresinski SC, Stevens DA. Caspofungin. Clin Infect Dis. 2003;36:1445–57. https://doi.org/10.1086/375080.

Article  CAS  PubMed  Google Scholar 

Wu Y, Zhang M, Yang Y, et al.  Structures and mechanism of chitin synthase and its inhibition by antifungal drug Nikkomycin Z. Cell Discovery 2022;8:1 8:1–4. https://doi.org/10.1038/s41421-022-00495-y

Vermes A. Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J Antimicrob Chemother. 2000;46:171–9. https://doi.org/10.1093/jac/46.2.171.

Article  CAS  PubMed  Google Scholar 

Bennett JE. Flucytosine. Ann Intern Med. 1977;86:319–22. https://doi.org/10.7326/0003-4819-86-3-319.

Article  Google Scholar 

Belanger ES, Yang E, Forrest GN. Combination antifungal therapy: when, where, and why. Curr Clin Microbiol Rep. 2015;2:67–75. https://doi.org/10.1007/S40588-015-0017-Z.

Article  Google Scholar 

Beggs WH. Mechanisms of synergistic interactions between Amphotericin B and Flucytosine. J Antimicrob Chemother. 1986;17:402–4. https://doi.org/10.1093/JAC/17.4.402.

Article  CAS  PubMed  Google Scholar 

Kwon-Chung KJ, Fraser JA, Doering TL, et al. Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis. Cold Spring Harb Perspect Med. 2014;4:a019760–019760. https://doi.org/10.1101/cshperspect.a019760.

Article  PubMed  PubMed Central  Google Scholar 

Mroczyńska M, Brillowska-Dąbrowska A. Review on current status of echinocandins use. Antibiotics. 2020;2020(9):Page227–9227. https://doi.org/10.3390/ANTIBIOTICS9050227.

Article  Google Scholar 

Wambaugh MA, Denham ST, Ayala M, et al. Synergistic and antagonistic drug interactions in the treatment of systemic fungal infections. Elife. 2020;9:1–26. https://doi.org/10.7554/eLife.54160.

Article  Google Scholar 

Odds FC. Interactions among amphotericin B, 5-Fluorocytosine, Ketoconazole, and Miconazole against pathogenic fungi in vitro. Antimicrob Agents Chemother. 1982;22:763–70. https://doi.org/10.1128/AAC.22.5.763.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hamadeh IS, Klinker KP, Borgert SJ, et al. Impact of the CYP2C19 genotype on Voriconazole exposure in adults with invasive fungal infections. Pharmacogenet Genomics. 2017;27:190–6. https://doi.org/10.1097/FPC.0000000000000277.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou SF, Liu JP, Chowbay B. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab Rev. 2009;41:89–295. https://doi.org/10.1080/03602530902843483.

Article  CAS  PubMed  Google Scholar 

Shitara Y. Clinical importance of OATP1B1 and OATP1B3 in drug-drug interactions. Drug Metab Pharmacokinet. 2011;26:220–7. https://doi.org/10.2133/DMPK.DMPK-10-RV-094.

Article  CAS  PubMed  Google Scholar 

Mao Q, Unadkat JD. Role of the breast cancer resistance protein (BCRP/ABCG2) in drug transport - an update. AAPS J. 2015;17:65–82. https://doi.org/10.1208/S12248-014-9668-6.

Article  CAS  PubMed  Google Scholar 

Chou TC. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 2010;70:440–6. https://doi.org/10.1158/0008-5472.CAN-09-1947.

Article  CAS  PubMed  Google Scholar 

Cleveland WS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc. 1979;74:829–36. https://doi.org/10.1080/01621459.1979.10481038.

Article  Google Scholar 

Johnson MD, MacDougall C, Ostrosky-Zeichner L, et al. Combination antifungal therapy. Antimicrob Agents Chemother. 2004;48:693. https://doi.org/10.1128/AAC.48.3.693-715.2004.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ahearn DG, McGlohn MS. In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to Amphotericin B, 5-Fluorocytosine, Miconazole, and Ketoconazole. J Clin Microbiol. 1984;19:412–6. https://doi.org/10.1128/jcm.19.3.412-416.1984.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barchiesi F, Di Francesco LF, Compagnucci P, et al. In vitro interaction o